Neumora Therapeutics (NMRA) Stock Chart & Stock Price History $1.46 -0.19 (-11.52%) Closing price 04:00 PM EasternExtended Trading$1.49 +0.03 (+2.05%) As of 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Neumora Therapeutics Stock Price Performance The Neumora Therapeutics (NMRA) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 87.01%, with a year-to-date return of -86.23%. In the past month, the stock has increased 61.92%, reflecting recent market activity. As of the latest close, Neumora Therapeutics traded at $1.65 with a market cap of $257.18 million and volume of 1.27 million shares. Receive NMRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-6.41%1 Month Performance+61.92%3 Month Performance+130.65%Year-To-Date Performance-86.23%1 Year Performance-87.01% NMRA Stock Chart for Friday, August, 8, 2025 NMRA Chart by TradingView Neumora Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$1.65$1.46-11.52%$1.69$1.43795,418 shs$236.16 million08/07/2025$1.59$1.65+3.77%$1.70$1.591.27 million shs$257.18 million08/06/2025$1.66$1.59-4.22%$1.66$1.541.06 million shs$257.18 million08/05/2025$1.65$1.66+0.61%$1.72$1.591.21 million shs$268.51 million08/04/2025$1.56$1.65+5.77%$1.79$1.621.15 million shs$266.88 million08/01/2025$1.96$1.56-20.41%$1.92$1.522.11 million shs$252.33 million07/31/2025$2.08$1.96-5.77%$2.12$1.95850,628 shs$317.03 million07/30/2025$2.19$2.08-5.02%$2.22$1.991.01 million shs$336.44 million07/29/2025$2.28$2.19-3.95%$2.35$2.091.84 million shs$354.23 million07/28/2025$2.35$2.28-2.98%$2.40$2.122.56 million shs$368.79 million Get the Latest News and Ratings for NMRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$2.29$2.35+2.62%$2.85$2.224.27 million shs$380.11 million07/24/2025$1.85$2.29+23.78%$2.35$1.852.99 million shs$370.41 million07/23/2025$1.89$1.85-2.12%$1.93$1.701.31 million shs$299.23 million07/22/2025$1.96$1.89-3.57%$1.98$1.801.39 million shs$305.71 million07/21/2025$1.85$1.96+5.95%$2.07$1.852.19 million shs$317.03 million07/18/2025$1.71$1.85+8.19%$2.17$1.735.28 million shs$299.24 million07/17/2025$1.40$1.71+22.14%$1.75$1.402.46 million shs$276.59 million07/16/2025$1.45$1.40-3.45%$1.58$1.311.59 million shs$226.45 million07/15/2025$1.27$1.45+14.17%$1.50$1.252.02 million shs$234.54 million07/14/2025$1.29$1.27-1.55%$1.34$1.142.28 million shs$205.42 million07/11/2025$1.06$1.29+21.70%$1.41$1.015.30 million shs$208.66 million07/10/2025$1.02$1.06+3.92%$1.13$1.001.44 million shs$171.45 million07/09/2025$0.90$1.02+13.12%$1.18$0.903.15 million shs$164.99 million07/08/2025$0.90$0.90+0.71%$0.95$0.85750,121 shs$145.85 million07/07/2025$0.81$0.90+10.39%$0.93$0.791.16 million shs$144.81 million Related Companies Structure Therapeutics Stock Chart Amphastar Pharmaceuticals Stock Chart Verve Therapeutics Stock Chart Spyre Therapeutics Stock Chart Akebia Therapeutics Stock Chart Arcus Biosciences Stock Chart Collegium Pharmaceutical Stock Chart Anavex Life Sciences Stock Chart Immunome Stock Chart Enliven Therapeutics Stock Chart Receive NMRA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Neumora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NMRA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | SponsoredShocked one of my clients with thisTrump Schedules Controversial 'Market Reset' for September 30 Behind closed doors, the White House has orde...Altimetry | SponsoredCritical AI announcement set to ignite AI 2.0 While the market chops sideways and headlines dominate the news cycle, a small group of traders is quietly tak...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Neumora Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Neumora Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMRA Stock Alerts